173 related articles for article (PubMed ID: 28167504)
1. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.
Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M
Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504
[TBL] [Abstract][Full Text] [Related]
2. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth.
Wang M; Hossain MS; Tan W; Coolman B; Zhou J; Liu S; Casey PJ
Oncogene; 2010 Sep; 29(35):4959-70. PubMed ID: 20622895
[TBL] [Abstract][Full Text] [Related]
4. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
Chai TF; Manu KA; Casey PJ; Wang M
Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
[TBL] [Abstract][Full Text] [Related]
5. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.
Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M
Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967
[TBL] [Abstract][Full Text] [Related]
6. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
Pan Q; Liu R; Banu H; Ma L; Li H
Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
[TBL] [Abstract][Full Text] [Related]
8. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
[TBL] [Abstract][Full Text] [Related]
9. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.
Court H; Amoyel M; Hackman M; Lee KE; Xu R; Miller G; Bar-Sagi D; Bach EA; Bergö MO; Philips MR
J Clin Invest; 2013 Nov; 123(11):4681-94. PubMed ID: 24216479
[TBL] [Abstract][Full Text] [Related]
10. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
11. 6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
Zhao Y; Fan D; Ru B; Cheng KW; Hu S; Zhang J; Li ET; Wang M
Eur J Cancer; 2016 Nov; 68():38-50. PubMed ID: 27710830
[TBL] [Abstract][Full Text] [Related]
12. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia.
Marín-Ramos NI; Balabasquer M; Ortega-Nogales FJ; Torrecillas IR; Gil-Ordóñez A; Marcos-Ramiro B; Aguilar-Garrido P; Cushman I; Romero A; Medrano FJ; Gajate C; Mollinedo F; Philips MR; Campillo M; Gallardo M; Martín-Fontecha M; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2019 Jul; 62(13):6035-6046. PubMed ID: 31181882
[TBL] [Abstract][Full Text] [Related]
13. Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair.
Tang J; Casey PJ; Wang M
Life Sci Alliance; 2021 Dec; 4(12):. PubMed ID: 34610973
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
[TBL] [Abstract][Full Text] [Related]
15. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
Cushman I; Casey PJ
J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
[TBL] [Abstract][Full Text] [Related]
16. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
[TBL] [Abstract][Full Text] [Related]
17. Regulation of NOTCH signaling by RAB7 and RAB8 requires carboxyl methylation by ICMT.
Court H; Ahearn IM; Amoyel M; Bach EA; Philips MR
J Cell Biol; 2017 Dec; 216(12):4165-4182. PubMed ID: 29051265
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ICMT induces endothelial cell apoptosis through GRP94.
Lu Q; Harrington EO; Newton J; Jankowich M; Rounds S
Am J Respir Cell Mol Biol; 2007 Jul; 37(1):20-30. PubMed ID: 17347446
[TBL] [Abstract][Full Text] [Related]
19. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
20. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
